Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
OpenNano is Scopus-indexed (Q1, CiteScore 17.3), DOAJ. Published by Elsevier Inc..
Checked against the index lists dated .
ISSN 2352-9520Verify ISSN ↗
Publisher: Elsevier Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 6 / 278 | 98th | Q1 |
| Pharmaceutical Science | 7 / 191 | 96th | Q1 |
| Internal Medicine | 9 / 179 | 95th | Q1 |
| Biotechnology | 19 / 325 | 94th | Q1 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present (also 2016–2019), best quartile Q1, CiteScore 17.3.
OpenNano is Q1 in Pharmacology (medical) (rank 6 of 278), Q1 in Pharmaceutical Science (rank 7 of 191) and Q1 in Internal Medicine (rank 9 of 179), by CiteScore 2025. It is ranked in 4 subject areas in all.
OpenNano is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 17.3, quartile Q1, 98th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.184, quartile Q1, with an H-index of 38.
The publisher lists an article processing charge of about US$1,860 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
OpenNano is published by Elsevier Inc. Its ISSN is 2352-9520.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
OpenNano has an h-index of 46 and a 2-year mean of 5.56 citations per paper (OpenAlex). Its Scopus CiteScore is 17.3, quartile Q1. On 2-year citations it ranks #20 of 271 Scopus journals in Pharmacology (medical).
OpenNano published 47 papers in 2025; its busiest recent year was 2022 with 80. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2024–2026), authors are most often from Thailand (19.1%), Indonesia (17.1%) and India (8.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (13.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.